Funding from the Horizon 2020 SME Instrument

Gradientech receives funding in the latest call for the phase 1 of the Horizon SME Instrument program. The SME Instrument phase 1 funding will support our continued market driven development of our diagnostic system for rapid antibiotic susceptibility testing (AST), with focus on exploring the US market and finalizing the clinical validation plans for the intended CE-marking of the system.